Related Experiment Video
Updated: Aug 12, 2025
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.0K
Concomitant Mitral Valve Repair vs Replacement During Surgical Ventricular Restoration for Ischemic Cardiomyopathy
Amr A Arafat1,2, Rawan Alghamdi1, Juan J Alfonso3
1Adult Cardiac Surgery Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Angiology
|January 29, 2023
Summary
Mitral valve repair (MVr) or replacement (MVR) during surgical ventricular restoration (SVR) for ischemic cardiomyopathy both offer valid options. Long-term survival rates were comparable between the two surgical approaches in this patient cohort.
Area of Science:
- Cardiovascular Surgery
- Heart Failure Management
- Valvular Heart Disease
Background:
- Ischemic cardiomyopathy often involves mitral regurgitation, complicating surgical ventricular restoration (SVR).
- Optimal mitral valve management during SVR remains debated, with repair (MVr) and replacement (MVR) as potential strategies.
Purpose of the Study:
- To compare the postoperative outcomes and long-term survival of patients undergoing SVR with either MVr or MVR.
Main Methods:
- A retrospective study of 112 patients who underwent SVR between 2009 and 2018.
- Patients were divided into two groups: MVr (n=75) and MVR (n=37).
- Clinical data, including preoperative risk factors, intraoperative variables, and postoperative outcomes (mortality, rehospitalization, survival), were analyzed.
Main Results:
- Patients undergoing MVR presented with more severe preoperative conditions, including lower ejection fraction and higher pulmonary artery pressures.
- Hospital mortality did not significantly differ between the MVr and MVR groups (9.33% vs 8.11%, P > .99).
- While freedom from rehospitalization showed a trend favoring MVr, long-term survival at 7 years was significantly better in the MVr group (74% vs 56%, P = .027), though adjusted survival did not differ.
Conclusions:
- Both mitral valve repair and replacement are viable options for patients undergoing SVR for ischemic cardiomyopathy.
- The choice between MVr and MVR should consider patient-specific factors and preoperative risk stratification.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
01:29Cardiomyopathy V: Interprofessional Care
22
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
01:25Mitral Regurgitation III: Medical Management
24
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
24
01:22Mitral Valve Prolapse II: Assessment and Management
35
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
35
01:20Mitral Regurgitation I: Introduction
28
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
28
01:27Mitral Valve Prolapse I: Introduction
31
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
31